⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
GKOS News
Glaukos Corporation
Glaukos Announces US FDA Approval of NDA Supplement Allowing for Re-Administration of iDose ® TR
businesswire.com
GKOS
Glaukos to Release Fourth Quarter and Full Year 2025 Financial Results after Market Close on February 17
businesswire.com
GKOS
Glaukos Announces Preliminary, Unaudited Fourth Quarter and Full Year 2025 Net Sales and Reaffirms 2026 Revenue Guidance
businesswire.com
GKOS
Glaukos Announces Participation in J.P. Morgan Healthcare Conference
businesswire.com
GKOS
Glaukos Announces Participation in Upcoming Investor Conferences
businesswire.com
GKOS
Glaukos Announces Third Quarter 2025 Financial Results
businesswire.com
GKOS
Glaukos Innovation to be Highlighted at the 2025 American Academy of Ophthalmology Annual Meeting
businesswire.com
GKOS
Glaukos to Release Third Quarter 2025 Financial Results after Market Close on October 29
businesswire.com
GKOS
Glaukos Breaks Ground on New Research, Development, and Manufacturing Facility in Huntsville, Alabama
businesswire.com
GKOS